Surface Oncology agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of the Cambridge, Mass.-based biotech company’s SRF813, a fully human IgG1 antibody and immunotherapy designed to treat cancer.
AstraZeneca is acquiring Alexion Pharmaceuticals for $39 billion, with the deal expected to close in the third quarter of 2021.
Sanofi and GlaxoSmithKline said clinical trials of their Covid-19 vaccine showed an insufficient immune response in older people, delaying its launch to late 2021 and marking a setback in the global fight against the pandemic.
Can Janssen Cure Cancer? Company’s 80+ ASH Presentations Suggest It’s On Right Track
American Society of Hematology (ASH) Annual Meeting, B-cell maturation antigen (BCMA), Cancer, Clinical Data, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Hematology, Janssen, Johnson & Johnson, R&D, Relapse/Refractory Multiple Myeloma, T-Cells, TherapeuticsThe Janssen Pharmaceutical Companies of Johnson & Johnson has a presence in more than 80 of the hematology studies presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition in December.
FDA Approves Roche Covid-19 Test that Aims to Test Vaccines’ Antibody Response
Antibody Response, Blood, Blood Samples, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Antibodies, COVID-19 Testing, CoVIg-19 Plasma Alliance, Emergency Use Authorization, FDA, Moderna, Pfizer, SARS-CoV-2 spike protein, Testing LabsThe U.S. Food and Drug Administration gave Emergency Use Authorization (EUA) to a Covid-19 test developed by Roche that measures antibodies within the blood.
Biomarkers will be critical to developing precision medicine for Alzheimer’s disease, and phosphorylated tau (P-tau) may enable earlier and more accurate detection, according to Eli Lilly-associated researchers.
AI Can Detect Covid-19 by Analyzing Coughs and More Related Research
ACE2 (angiotensin-converting enzyme-2), Antibodies, Artificial Intelligence, Blood Samples, Brigham and Women's Hospital, Cells, Children, Coronavirus Disease 2019 (COVID-19), Cough, Massachusetts Institute of Technology (MIT), Mouth, R&D, Researchers, RNA, Science Translational MedicineResearchers at Massachusetts Institute of Technology (MIT) developed an artificial intelligence (AI) model able to detect asymptomatic Covid-19 cases by identifying differences in the sounds of coughs between healthy and infected people.
Caris Life Sciences secured $310 million in growth capital that will be used to expand the molecular science company’s presence in precision medicine in oncology.
Johns Hopkins Scientists Discover Possible Key to Controlling Covid-19 Immune Response
Biological, Blood, Cells, Coronavirus Disease 2019 (COVID-19), Factor D Protein, Immune System, Inflammation, Johns Hopkins University School of Medicine, Membranes, R&D, Researchers, SARS-CoV-2 spike protein, Sugar MoleculesResearchers at Johns Hopkins Medicine identified a protein – known as factor D – that appears essential to the inflammatory process of SARS-CoV-2, the virus that causes Covid-19.
Roche’s Venclexta Granted Full Approval Under Project Orbis and Real-Time Review
Accelerated Approval, Acute Myeloid Leukemia (AML), Adults 75 or older, Approvals, B-cell lymphoma-2 (BCL-2) protein, Chemotherapy, Clinical Trials, FDA/Regulatory, Full Approval, Project Orbis, R&D, Real-Time Oncology Review (RTOR) PilotThe U.S. Food and Drug Administration granted Roche’s Venclexta (venetoclax) full approval in combination with azacytidine, or decitabine, or low-dose cytarabine for newly diagnosed acute myeloid leukemia in adults 75 years or older.